Newsstand Menu

Home / Newsstand / CSHL Stories and Media

CSHL Stories and Media archive for Tag: David Tuveson

Filter by tag

$11 million investment to develop fibroblast therapeutic

4/26/2021

CSHL Professor David Tuveson and other leading disease experts founded a company to target fibroblasts as a new way to treat cancer and inflammatory diseases. Read the story »

Dr. David Tuveson inaugurated as AACR president

4/21/2021

CSHL Cancer Center Director David Tuveson is leading the American Association for Cancer Research. Read the story »

photo of Dennis Plenker working at the organoid facility

CSHL’s new organoid facility

11/5/2020

The 2,200 square foot facility will make and maintain hundreds of live tissue models grown from patient tumors. Read the story »

One experiment: Organoids as living laboratories

10/30/2020

These tiny balls of cells are revolutionizing the research and treatment of pancreas and other types of cancers. Read the story »

photo of a medical consult with a cancer patient

New genetic research to understand racial disparity in cancers

9/8/2020

Cold Spring Harbor Laboratory will study the genetic contributions of ethnicity to colon, endometrial, and pancreas cancers in African Americans. Read the story »

photo of graduate school diploma and gown

Cold Spring Harbor Laboratory’s class of 2020

8/7/2020

Meet the seven graduates of the Cold Spring Harbor Laboratory School of Biological Sciences. Congratulations to all. Read the story »

Hero image with organoid and Dr. David Tuveson for Live @ the Lab

Live @ the Lab with David Tuveson: Studying pancreatic cancer

7/29/2020

Cold Spring Harbor Laboratory Cancer Center Director Dave Tuveson presents an exciting new model for studying pancreatic cancer. Watch the video »

Cancer researchers discuss COVID-19’s effect on the field

7/27/2020

Dr. David Tuveson and Dr. Tobias Janowitz discuss in Cancer Discovery how the COVID-19 pandemic has changed cancer research. Read the story »

The first mouse model of human pancreas cancer subtypes

7/23/2020

CSHL researchers discovered how slow-growing pancreatic tumors can switch into a more deadly sub-type. Read the story »

image of pancreatic tumor organoids in mouse

Blocking cholesterol storage could stop growth of pancreatic tumors

7/7/2020

Interfering with the way pancreatic cancer cells process and store cholesterol can stop a tumor from growing. Read the story »

Applying symptom tracking to COVID-19 outpatient care using famotidine

6/4/2020

Researchers from CSHL and Northwell Health are developing a way to test promising COVID-19 drugs, like famotidine, by tracking outpatient symptoms. Read the story »

Tuveson and Wigler elected AACR Academy Fellows

5/12/2020

CSHL Cancer Center Director David Tuveson and Professor Michael Wigler were chosen as 2020 Fellows of the AACR Academy. Read the story »

David Tuveson named President-Elect of AACR

4/21/2020

CSHL Cancer Center Director David Tuveson has been elected President-Elect of the American Association for Cancer Research. Read the story »

photo of David Tuveson and lab assistant

CSHL Cancer Center joins the AACI

1/10/2020

The CSHL Cancer Center becomes the 100th member of the Association of American Cancer Institutes. Read the story »

CSHL investigators rank among world’s most highly cited

12/11/2019

Seven researchers affiliated with CSHL are among the scientists producing the top 1 percent of the most highly-cited research in the world. Read the story »